FDA panel unanimously backs cobas HPV test as primary screening tool

The FDA usually follows the recommendations of its advisory panels.

Advisory panel members have been cleared of potential conflicts related to the meeting topic. Occasionally, a panelist is given a waiver, but no waivers were given at this meeting.

emechcatie@frontlinemedcom.com